Syndax Pharmaceuticals (SNDX) Interest Coverage Ratio Growth (1y) (2021 - 2025)
Syndax Pharmaceuticals (SNDX) Interest Coverage Ratio Growth (1y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Syndax Pharmaceuticals |
1.69 Bn |
1.34 Bn |
53.02 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2025 |
-951.28% |
| Mar 31, 2025 |
-4,482.12% |
| Dec 31, 2024 |
162.85% |
| Sep 30, 2024 |
-383.76% |
| Jun 30, 2024 |
-16.20% |
| Mar 31, 2024 |
20.55% |
| Dec 31, 2023 |
-26.50% |
| Sep 30, 2023 |
-3,904.62% |
| Jun 30, 2023 |
-2,514.95% |
| Mar 31, 2023 |
-1,931.84% |
| Dec 31, 2022 |
92.85% |
| Sep 30, 2022 |
34.87% |
| Jun 30, 2022 |
-54.08% |
| Mar 31, 2022 |
-29.86% |
| Dec 31, 2021 |
-43,635.16% |
| Sep 30, 2021 |
1.27% |
| Jun 30, 2021 |
-35.31% |
| Mar 31, 2021 |
-29.65% |
